Organon shareholders approve Sun Pharma takeover

Organon & Co. stockholders voted on July 24, 2026 to approve their merger with Shanghvi's Sun Pharma, clearing a major hurdle for the roughly $11.75 billion enterprise-value deal, Outlook Business reported. Sun Pharma said it expects to close the acquisition by early 2027, subject to regulatory approvals.